Objective-To assess by echocardiography the occurrence and degree of late cardiac sequelae after treatment for Hodgkin's disease by radiation and chemotherapy. Patients and methods-In Norway from 1980 to 1988, 129 patients < 50 years old with Hodgkin's disease had curative treatment with mediastinal radiation, with or without chemotherapy. 116 (90%) of these patients (mean (SD) age 37 (7) years, 67 males) were examined by echocardiography 5-13 years after treatment. 40 healthy individuals (mean (SD) age 40 (11), 20 males) were examined as controls. All those examined were in regular sinus rhythm. Results-Grade > 1 (scale 0-3) aortic and/or mitral valvar regurgitation was found in 24% of the patients (15% aortic, 7% mitral, and 2% aortic + mitral), affecting 46% of the females v 16% of the males (P < 0.001). Female gender was a significant risk factor for aortic and mitral regurgitation (odds ratio 4-7, 95% confidence interval 2-0 to 11.2), whereas age, period of follow up, radiation dose, and chemotherapy were not. Thickened pericardium was diagnosed in 15% of the patients. No risk factors were identified. No cases of pericardial thickening or valvar regurgitation grade > 1 were recorded in the control group. Mean values for measured and calculated indices of systolic and diastolic function were within the normal range for patients and controls. The patients had reduced EIA ratio compared with the healthy controls (E/A 1.1 v 2-0, P < 0.001).
Hodgkin's disease provides a clinical model for studying long-term effects of cancer treatment. Mainly young adults are affected, and more than 70% are cured' by radiotherapy alone or combined with chemotherapy. Both treatments are potentially cardiotoxic. 2 Radiation-induced cardiac injury includes pericarditis, coronary artery stenosis, myocardial fibrosis, and valvar dysfunction. 3 One of the standard chemotherapy regimens used in Hodgkin's disease includes anthracyclines, agents known to induce cardiomyopathy that may progress to fatal heart failure. 4 The toxicity of anthracyclines may be enhanced by multidrug combinations and additional radiation. 5 In Norway, up until 1988, all patients with Hodgkin's disease were treated at one centre. The patients were recruited from the entire country, were referred and selected according to uniform criteria, and had standardised treatment procedures. Today this policy has provided us with a well defined national patient population available for long-term follow up.
Echocardiography has been used in only one large clinical study to evaluate the longterm toxicity of high-dose mediastinal radiation. 6 In our national cohort of Hodgkin disease survivors, we aimed to assess the occurrence and degree of late cardiac sequelae after such treatment.
Patients and methods

PATIENTS
The study was based on all 427 consecutive patients who were treated for Hodgkin's disease at the Norwegian Radium Hospital during the period 1980-88. By 1 January 1993, 282 of these patients were still alive. The study was limited to patients who had been treated with standardised mediastinal radiation alone or in combination with chemotherapy. Only patients aged under 50 years at the time of diagnosis and who had been in complete remission for more than five years at the time of follow up were invited to participate. Of the 129 patients invited, 13 were lost to follow up. The remaining 116 patients (90%) were enrolled in the study, after giving their signed informed consent. The study was approved by the Regional Ethics Committee.
Hodgkin's disease had been diagnosed on the basis of histopathological examination of a lymph-node biopsy specimen. Radiation Forty healthy subjects (20 males and 20 females, mean (SD) age 40 (11) years) were recruited as a reference group. There were about 10 individuals in each decade between 20 and 60 years. None had a history of cardiovascular disease or hypertension and no medication was being taken. Physical examination was normal in all. Echocardiography included Doppler examination of the aortic, mitral, and tricuspid valves.
ECHOCARDIOGRAPHY
We used a Vingmed CFM 700 or 750 ultrasound device (Vingmed Sound, Horten, Norway) with a duplex mechanical annular array probe (3-25 mhz for imaging tissue and 2-5 mhz for Doppler recordings). The subjects id been given in were examined in the lateral recumbent posim respectively. tion after 15 minutes of rest. The heart was were: doxoru-visualised by standard ultrasonic techniques and epirubicin and acoustic windows. Dimensions were determined by M mode echocardiography or a cross sectional technique when appropriate. Pulsed, continuous, and colour Doppler VPP or MVPP echocardiography in at least three planes was azine, and pred-used to assess valvar function. oatients. Table 1 shows the criteria for quantifying valvar regurgitation.9 10 The ratio between the diameters of the regurgitant jet and the outled a structured flow tract was used as main quantitative criteal examination. rion for the grading of aortic regurgitation. symptoms and Main criteria for the grading of mitral and triUse of medica-cuspid regurgitation were the ratios between L's disease treat-the areas of the respective jets and the atrial patients were areas. The jet length was the main criterion for 4ew York Heart grading pulmonary regurgitation. The other ration. Previous variables (table 1) were used as supporting cri-J for the occur-teria. Regurgitation satisfying the echocardiocluding cardiac graphic jet size criteria of grade 1 were defined fever) before as grade 1 (120/80 mmHg v 130/80 mmHg) and body surface area (1 9 m2 v 1-8 m2) . Regular sinus rhythm was present in all subjects.
For both male and female patients the mean values for all measured and calculated echocardiographic indices were within the normal range (table 3) , and differed significantly from the healthy controls only for the ratio between peak early (E) and late (A) diastolic transmitral flow velocities (E/A 1 1 v 2 0, P < 0001). The patients with coronary artery disease and hypertension were comparable with the rest of the patients with respect to E/A ratio (E/A 1.1 v 1 0). No significant differences in indices of systolic and diastolic function were seen between the two treatments, nor could we demonstrate a quantitative or qualitative effect of anthracylines. Thickened pericardium was noted in 18 (15%) of the patients. They all had normal atrial dimensions, shortening fraction of the left ventricle, and cardiac index. The E/A ratio was below 0-8 in four, but the deceleration time of peak early velocity was normal in all. We found no association between pericardial thickening and sex, age, period of follow up, or treatment. No abnormality of the pericardium was detected in the controls.
Five patients had increased echoes from the aortic valve without showing a gradient. Three of them had no regurgitation, the fourth had dilatation of the aortic annulus and root with grade 2 regurgitation and the fifth had regurgitation grade 1-2. In no other patients were structural abnormalities observed. Valvar thickening was not recorded in the control group. Table 4 shows the occurrence and degree of valvar regurgitation in patients and controls.
In 36 patients (31%), 40 valves with pathological (that is, grade > 1) regurgitation were recorded at the aortic valve in 18 patients, at the mitral valve in eight, at both the aortic and mitral valve in two, at the tricuspid valve in four, at both the mitral and tricuspid in two, and at the pulmonary valve in two. Patients with aortic and mitral regurgitation grade > 1 had higher left ventricular end diastolic diameters than the rest of the patients (2-7 v 2-5 cm/M2i, P < 0O001). Those with pathological mitral regurgitation also had increased left atrium diameter (1 9 v 1-6 cm/M2, P = 001); but none had dimensions outside the normal limits.
Aortic and/or mitral regurgitation grade > 1 was detected in all patients who had cardiac murmurs. No cases of valvar stenosis were recorded. We found no dose-response effect of radiation dose or fractionation on the occurrence of valvar regurgitation. Grade > 1 regurgitation occurred in 49% of the female patients and in 18% of the males (P < 0 001).
When we controlled for sex, age, follow up period, radiation dose, and chemotherapy in a logistic regression model, sex was the only significant predictor for grade > 1 regurgitation (odds ratio 4 7, 95% confidence interval 2-0 to 11 2) . No subject in the reference group had regurgitation grade > 1 (table 4) and none had valvar stenosis.
Discussion
The major finding of this study was that abnormal aortic regurgitation (that is, grade > 1) was diagnosed in 17% of the patients. Compared with our control group and with another reference material,"5 both the proportion and severity of aortic regurgitation were outside the normal physiological range.'5 16 Our findings do not accord with the prevailing opinion that valvar dysfunction is a rare sequelae after mediastinal radiotherapy,3 an assumption based mainly on studies from the pre-Doppler era. ' Female patients were at increased risk of valvar regurgitaton. This difference between the sexes was not found in our reference group or in other prevalence studies of healthy subjects.'516 Studies of radiation-associated valvar disease seem to include a majority of women.2021 We cannot explain why females in our study group should be more susceptible to valvar injury than males. They were comparable in terms of baseline clinical characteristics, they were treated with the same radiation technique, and they received the same dose to the heart. Chemotherapy, with or without anthracyclines, did not increase the risk of valvar dysfunction. This suggests that radiation itself is the prime cause of valvar injury. Because the range of doses was narrow (40-42 Gy) we were unable to demonstrate a dose-response effect of radiation.
Pericardial thickening was recorded in 15% of our patients, in most cases there was no sign of haemodynamic impairnent. Previous studies have reported a variable prevalence of pericardial pathology.6 1819 This inconsistency may partly be due to patient selection and partly to differences in radiation technique.
For the patients, as a group, the mean values for measured and calculated indices of systolic and diastolic function were within the normal range. However, compared with the healthy controls, the patients had a significantly reduced E/A ratio, implying that filling of the ventricle occurred later in the diastole. We found no significant differences in myocardial function between patients who had received additional chemotherapy and those treated with radiation only. This is probably because the median cumulative dose of anthracyclines had been kept well below the recommended threshold dose. 4 We diagnosed left-sided valvar regurgitation in a high proportion of long-term survivors of Hodgkin's disease. Most noteworthy is the high prevalence of significant aortic regurgitation, and the increased risk of valvar lesions in female patients. We recommend echocardiographic screening after high-dose mediastinal radiation to identify patients with valvar patholgy and assess their need for endocarditis prophylaxis, treatment, or follow up.
